During the past decade, Diagnostic and Consulting Center "Aleksandrovska" EOOD conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Diagnostic and Consulting Center "Aleksandrovska" EOOD" #1 sponsor was "Shire" with 5 trials, followed by "Celgene" with 3 trials sponsored, "Assembly Biosciences" with 2 trials sponsored, "Enanta Pharmaceuticals, Inc" with 1 trials sponsored and "Fresenius Kabi SwissBioSim GmbH" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diagnostic and Consulting Center "Aleksandrovska" EOOD" #1 collaborator was "Arbutus Biopharma Corporation" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Diagnostic and Consulting Center "Aleksandrovska" EOOD" are "Crohn Disease" (3 trials), "Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Chronic Hepatitis B" (2 trials) and "Helicobacter Pylori Infection" (1 trials). Many other conditions were trialed in "Diagnostic and Consulting Center "Aleksandrovska" EOOD" in a lesser frequency.

Most popular intervention types in "Diagnostic and Consulting Center "Aleksandrovska" EOOD" are "Drug" (14 trials), "Other" (5 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Ontamalimab" (4 trials), "Ozanimod" (3 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diagnostic and Consulting Center "Aleksandrovska" EOOD" are 13 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Diagnostic and Consulting Center "Aleksandrovska" EOOD". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Diagnostic and Consulting Center "Aleksandrovska" EOOD, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Diagnostic and Consulting Center "Aleksandrovska" EOOD, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".